ClinicalTrials.Veeva

Menu

Electroencephalography Study Investigating the Effects of Vortioxetine in Healthy Male Subjects

Lundbeck logo

Lundbeck

Status and phase

Completed
Phase 1

Conditions

Healthy Men

Treatments

Drug: Escitalopram 15 mg
Drug: Placebo
Drug: Vortioxetine 10 mg
Drug: Vortioxetine 20 mg

Study type

Interventional

Funder types

Industry

Identifiers

NCT02072278
2013-004015-53 (EudraCT Number)
15835A

Details and patient eligibility

About

To explore a neurophysiological marker (electroencephalography) of cognitive effect of vortioxetine

Enrollment

32 patients

Sex

Male

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • The subject has a normal resting EEG at screening visit
  • The subject is able to perform tasks with an auditory stimulus
  • The subject is not visually impaired - normal prescription glasses are accepted
  • The subject has a normal circadian rhythm, defined as a person who usually wakes between 6:00 and 9:00 a.m. and goes to sleep between 9:00 pm and midnight.

Exclusion criteria

  • The subject has worked shifts, including night duty, or has travelled across >3 time zones <2 weeks prior to the first dose of IMP.

Other inclusion and exclusion criteria may apply.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

32 participants in 4 patient groups, including a placebo group

Vortioxetine 10 mg
Experimental group
Description:
encapsulated tablets; 3 daily doses in each treatment period; orally
Treatment:
Drug: Vortioxetine 10 mg
Vortioxetine 20 mg
Experimental group
Description:
encapsulated tablets; 3 daily doses in each treatment period; orally
Treatment:
Drug: Vortioxetine 20 mg
Escitalopram 15 mg
Active Comparator group
Description:
encapsulated tablets; 3 daily doses in each treatment period; orally
Treatment:
Drug: Escitalopram 15 mg
Placebo
Placebo Comparator group
Description:
capsules; 3 daily doses in each treatment period; orally
Treatment:
Drug: Placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems